Cargando…

Coronary Stent Thrombosis: Current Insights into New Drug-Eluting Stent Designs

The advances of interventional cardiology have been achieved by new device development, finding appropriate drug regimes, and understanding of pathomechanism. Drug-eluting stents (DES) implantation with dual anti-platelet therapy reduced revascularization without increasing mortality or myocardial i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun Kuk, Jeong, Myung Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chonnam National University Medical School 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539093/ https://www.ncbi.nlm.nih.gov/pubmed/23323218 http://dx.doi.org/10.4068/cmj.2012.48.3.141

Ejemplares similares

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence
por: Condello, Francesco, et al.
Publicado: (2023)

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)

Very Late Stent Thrombosis after Drug-Eluting Stent Implantation in a Patient without Aspirin and Clopidogrel Resistance
por: Lim, Sang Yup, et al.
Publicado: (2008)

Pathological Perspective of Drug-Eluting Stent Thrombosis
por: Inoue, Katsumi
Publicado: (2012)

Pathogenesis of late in-stent thrombosis after treatment with drug-eluting stents
por: Hao, Hiroyuki
Publicado: (2012)

Very Late Thrombosis of a Drug-Eluting Stent After Discontinuation of Dual Antiplatelet Therapy in a Patient Treated With Both Drug-Eluting and Bare-Metal Stents
por: Kim, Sung Soo, et al.
Publicado: (2009)

A Bumpy and Winding but Right Path to Domestic Drug-Eluting Coronary Stents
por: Cho, Jae Yeong, et al.
Publicado: (2013)

Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation
por: Kee, Won Ju, et al.
Publicado: (2011)

Early definite stent thrombosis with everolimus-eluting stents
por: Naito, Ryo, et al.
Publicado: (2015)

Intravascular Ultrasound-Guided Treatment for In-stent Restenosis Associated with Stent Fracture in Overlapped Drug-eluting Stents
por: Kim, Min Chul, et al.
Publicado: (2019)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents
por: Brami, Pierre, et al.
Publicado: (2023)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Association of Localized Hypersensitivity and In-Stent Neoatherosclerosis with the Very Late Drug-Eluting Stent Thrombosis
por: Yamaji, Kyohei, et al.
Publicado: (2014)

Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents
por: Varenhorst, Christoph, et al.
Publicado: (2018)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Development of Novel Drug-Eluting Stents for Acute Myocardial Infarction
por: Sim, Doo Sun, et al.
Publicado: (2017)

The potential hazard of drug-eluting stent-induced coronary vasospasm causing subacute stent thrombosis: a case report
por: Shibutani, Hiroki, et al.
Publicado: (2016)

Drug-eluting stents: insights into safety and indications
por: Hassan, Walid
Publicado: (2008)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2015)

Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries in Patients with Acute Myocardial Infarction
por: Sim, Doo Sun, et al.
Publicado: (2011)

Subacute Drug-Eluting Stent Thrombosis Caused by Stent Underexpansion: Evaluation by Optical Coherence Tomography
por: Martín-Reyes, Roberto, et al.
Publicado: (2011)

Extremely Late In-Stent Thrombosis 12 Years After Implantation of a Drug-Eluting Stent
por: Sleiman, Elsa, et al.
Publicado: (2020)

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis
por: Fujita, Hiroshi, et al.
Publicado: (2014)

Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and Thrombocytosis
por: Choi, Hong Sang, et al.
Publicado: (2011)

Multiple Sequential Complications After Sirolimus-Eluting Stent Implantation: Very Late Stent Thrombosis, Stent Fracture, In-Stent Restenosis, and Peri-Stent Aneurysm
por: Seol, Sang-Hoon, et al.
Publicado: (2009)

State-of-the-Art Stent Technology to Minimize the Risk of Stent Thrombosis and In-Stent Restenosis: Abluminal-Coated Biodegradable Polymer Drug-Eluting Stent
por: Kang, Dong Oh, et al.
Publicado: (2022)

Ureteral stent technology: Drug-eluting stents and stent coatings
por: Yang, Luo, et al.
Publicado: (2015)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Impact of an endothelial progenitor cell capturing stent on coronary microvascular function: comparison with drug-eluting stents
por: Choi, Woong Gil, et al.
Publicado: (2015)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

Comparison of Drug-eluting Coronary Stents, Bare Coronary Stents and Self-expanding Stents in Angioplasty of Middle Cerebral Artery Stenoses
por: Lee, Jong-Hyeog, et al.
Publicado: (2013)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

CURRENT DEVELOPMENTS IN DRUG ELUTING DEVICES: Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis
por: Spadaccio, Cristiano, et al.
Publicado: (2017)

Gender differences of in-hospital outcomes in patients undergoing percutaneous coronary intervention in the drug-eluting stent era
por: Kim, Hack-Lyoung, et al.
Publicado: (2019)

Reduction of In-Stent Restenosis and Inflammation with One Stent: New Concept of Sirolimus and Ascorbic Acid-Eluting Coronary Stent
por: Ryu, JiWung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bbpr3npife4sbq98i6btu7dqej